文献速递肿瘤 PET/CT骨显像与常规 SPECT

68Ga-DOTANOC PET/CT误判椎旁骨外血管瘤为神经源性肿瘤一例

68Ga-DOTANOC PET/CT in an Atypical Extraskeletal Paravertebral Hemangioma Mimicking as Neurogenic Tumor in a Known Case of Breast Cancer.
PubMed 文献 · Clin Nucl Med · 2019-01-01

本文报道一例乳腺癌患者中发现的椎旁骨外病变,68Ga-DOTANOC PET/CT显示生长抑素受体表达增高,后证实为血管瘤。作者指出椎体血管瘤的成骨活性是已知判读陷阱,该病例提示应将良性血管瘤纳入生长抑素受体高摄取病变的鉴别诊断。

要点

  • 68Ga-DOTANOC PET/CT中椎体血管瘤可因成骨活性出现假阳性摄取。
  • 椎旁骨外血管瘤可模拟神经源性肿瘤,应纳入良性鉴别诊断。
  • 判读时需注意胰腺钩突、炎症、成骨活性等已知陷阱。

核心结论

  • 椎旁骨外血管瘤可表现为68Ga-DOTANOC摄取增高,是生长抑素受体显像中罕见的良性鉴别诊断。

研究设计与样本

  • 单病例报告,来源于已知乳腺癌患者的68Ga-DOTANOC PET/CT评估。

主要发现

  • 乳腺癌患者中检出椎旁骨外病变,68Ga-DOTANOC摄取增高,后证实为血管瘤。

关键数值与推荐

  • 原文提及椎体血管瘤的成骨活性是68Ga-DOTANOC PET/CT的已知判读陷阱之一。

临床怎么用

  • 判读68Ga-DOTANOC PET/CT时,对生长抑素受体高摄取的椎旁病变应将血管瘤纳入良性鉴别。

局限性

  • 单病例报告,证据级别有限,结论需更多病例验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ga-DOTANOC PET/CT is well documented in evaluation of well-differentiated neuroendocrine tumors and in other lesions with somatostatin receptor expression such as pheochromocytoma, paraganglioma, neuroblastoma, meningioma, and mesenchymal tumors causing oncogenic osteomalacia. Causes of interpretative pitfalls include prominent pancreatic uncinate process activity, inflammation, osteoblastic activity (degenerative bone disease/fracture/vertebral hemangioma), splenunculi/splenosis, and others. We present a case of extraskeletal paravertebral lesion detected in a known case of breast cancer with increased Ga-DOTANOC uptake later proved to be hemangioma. This is a novel finding and should be kept as a rare benign differential in evaluation of lesions with somatostatin receptor expression.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Vadi SK, Mittal BR, Parihar AS, et al. 68Ga-DOTANOC PET/CT in an Atypical Extraskeletal Paravertebral Hemangioma Mimicking as Neurogenic Tumor in a Known Case of Breast Cancer. Clin Nucl Med. 2019. PMID: 30829863. doi:10.1097/RLU.0000000000002521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。